Abstract

In 1982 we opposed the universal substitution of netilmicin (Netillin - Kirby-Warrick) for gentamicin and tobramycin although it is said to be less toxic.¹ Bacterial endocarditis is an exception where netilmicin may sometimes be preferable to gentamicin,² for example in the elderly or those with impaired renal or vestibular function.³ We reassess the claimed advantages of netilmicin in the light of recent data.